FUBO vs GSK · P/E 19, rev $4.60B vs P/E 13, $103.31B cap
Fubotv Inc (FUBO) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Fubotv Inc (FUBO) is a broadcasting company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported FUBO revenue for 2026-06-30 was $4.60B. Net income was -$16.3M. Revenue was up 47.5% from 2026-03-31 to 2026-06-30. FUBO currently screens at market cap $1.25B and trailing P/E 19.2.
GSK does not have a complete income-statement cache yet.
FUBO currently screens at market cap $1.25B and trailing P/E 19.2. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the FUBO and GSK stock pages for the full models.
Not investment advice.